Xenon Pharmaceuticals (XENE) has released an update.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical firm, is set to present at the upcoming RBC Capital Markets Global Healthcare Conference in New York on May 14-15, 2024. The company’s top executives, including the CEO and CFO, will lead a fireside chat, and a live webcast will be available for investors and stakeholders on Xenon’s website. Xenon is renowned for its innovative pipeline targeting neurological and psychiatric conditions, aiming to address unmet medical needs such as epilepsy and depression.
For further insights into XENE stock, check out TipRanks’ Stock Analysis page.
